Considering the main targets showed by PPI network, we speculate that AKT1, MAPK1, EGFR, MTOR, and SRC may be the core potential targets of CL against hepatic fibrosis, and molecular docking was further performed. This evidence concerns the gene SRC and Hepatic fibrosis.